Trabectedin: ET 743, ecteinascidin 743, Yondelis.
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004149:Dioxoles / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015507:Drugs, Investigational / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin
D018906:Antineoplastic Agents, Alkylating; D004149:Dioxoles; D015507:Drugs, Investigational; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin